Is the huge rise in attention-deficit hyperactivity disorder (ADHD) diagnoses a pharma coup or public-health boon? Even longtime advocates for patients with the disorder worry that drug advertising has pushed medications on children--and now adults--who might be better treated by alternate means. Report (sub. req.)